Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Recombinant Protein Therapeutics market report explains the definition, types, applications, major countries, and major players of the Recombinant Protein Therapeutics market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Roche
Biogen
Amgen
Pfizer
Merck
Sanofi
Eli Lilly
J&J
Ligand
Bayer
By Type:
Recombinant Hormones
Interferons
Interleukins
Hematopoietic Growth Factors
Others
By End-User:
Diabetes
Dwarfism
Heart Disease
Cancer
Others
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Recombinant Protein Therapeutics Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Recombinant Protein Therapeutics Outlook to 2028- Original Forecasts
-
2.2 Recombinant Protein Therapeutics Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Recombinant Protein Therapeutics Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Recombinant Protein Therapeutics Market- Recent Developments
-
6.1 Recombinant Protein Therapeutics Market News and Developments
-
6.2 Recombinant Protein Therapeutics Market Deals Landscape
7 Recombinant Protein Therapeutics Raw Materials and Cost Structure Analysis
-
7.1 Recombinant Protein Therapeutics Key Raw Materials
-
7.2 Recombinant Protein Therapeutics Price Trend of Key Raw Materials
-
7.3 Recombinant Protein Therapeutics Key Suppliers of Raw Materials
-
7.4 Recombinant Protein Therapeutics Market Concentration Rate of Raw Materials
-
7.5 Recombinant Protein Therapeutics Cost Structure Analysis
-
7.5.1 Recombinant Protein Therapeutics Raw Materials Analysis
-
7.5.2 Recombinant Protein Therapeutics Labor Cost Analysis
-
7.5.3 Recombinant Protein Therapeutics Manufacturing Expenses Analysis
8 Global Recombinant Protein Therapeutics Import and Export Analysis (Top 10 Countries)
-
8.1 Global Recombinant Protein Therapeutics Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Recombinant Protein Therapeutics Export by Region (Top 10 Countries) (2017-2028)
9 Global Recombinant Protein Therapeutics Market Outlook by Types and Applications to 2022
-
9.1 Global Recombinant Protein Therapeutics Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Recombinant Hormones Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Interferons Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Interleukins Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Hematopoietic Growth Factors Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Recombinant Protein Therapeutics Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Diabetes Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Dwarfism Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Heart Disease Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Cancer Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Others Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Recombinant Protein Therapeutics Market Analysis and Outlook till 2022
-
10.1 Global Recombinant Protein Therapeutics Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Recombinant Protein Therapeutics Consumption (2017-2022)
-
10.2.2 Canada Recombinant Protein Therapeutics Consumption (2017-2022)
-
10.2.3 Mexico Recombinant Protein Therapeutics Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Recombinant Protein Therapeutics Consumption (2017-2022)
-
10.3.2 UK Recombinant Protein Therapeutics Consumption (2017-2022)
-
10.3.3 Spain Recombinant Protein Therapeutics Consumption (2017-2022)
-
10.3.4 Belgium Recombinant Protein Therapeutics Consumption (2017-2022)
-
10.3.5 France Recombinant Protein Therapeutics Consumption (2017-2022)
-
10.3.6 Italy Recombinant Protein Therapeutics Consumption (2017-2022)
-
10.3.7 Denmark Recombinant Protein Therapeutics Consumption (2017-2022)
-
10.3.8 Finland Recombinant Protein Therapeutics Consumption (2017-2022)
-
10.3.9 Norway Recombinant Protein Therapeutics Consumption (2017-2022)
-
10.3.10 Sweden Recombinant Protein Therapeutics Consumption (2017-2022)
-
10.3.11 Poland Recombinant Protein Therapeutics Consumption (2017-2022)
-
10.3.12 Russia Recombinant Protein Therapeutics Consumption (2017-2022)
-
10.3.13 Turkey Recombinant Protein Therapeutics Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Recombinant Protein Therapeutics Consumption (2017-2022)
-
10.4.2 Japan Recombinant Protein Therapeutics Consumption (2017-2022)
-
10.4.3 India Recombinant Protein Therapeutics Consumption (2017-2022)
-
10.4.4 South Korea Recombinant Protein Therapeutics Consumption (2017-2022)
-
10.4.5 Pakistan Recombinant Protein Therapeutics Consumption (2017-2022)
-
10.4.6 Bangladesh Recombinant Protein Therapeutics Consumption (2017-2022)
-
10.4.7 Indonesia Recombinant Protein Therapeutics Consumption (2017-2022)
-
10.4.8 Thailand Recombinant Protein Therapeutics Consumption (2017-2022)
-
10.4.9 Singapore Recombinant Protein Therapeutics Consumption (2017-2022)
-
10.4.10 Malaysia Recombinant Protein Therapeutics Consumption (2017-2022)
-
10.4.11 Philippines Recombinant Protein Therapeutics Consumption (2017-2022)
-
10.4.12 Vietnam Recombinant Protein Therapeutics Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Recombinant Protein Therapeutics Consumption (2017-2022)
-
10.5.2 Colombia Recombinant Protein Therapeutics Consumption (2017-2022)
-
10.5.3 Chile Recombinant Protein Therapeutics Consumption (2017-2022)
-
10.5.4 Argentina Recombinant Protein Therapeutics Consumption (2017-2022)
-
10.5.5 Venezuela Recombinant Protein Therapeutics Consumption (2017-2022)
-
10.5.6 Peru Recombinant Protein Therapeutics Consumption (2017-2022)
-
10.5.7 Puerto Rico Recombinant Protein Therapeutics Consumption (2017-2022)
-
10.5.8 Ecuador Recombinant Protein Therapeutics Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Recombinant Protein Therapeutics Consumption (2017-2022)
-
10.6.2 Kuwait Recombinant Protein Therapeutics Consumption (2017-2022)
-
10.6.3 Oman Recombinant Protein Therapeutics Consumption (2017-2022)
-
10.6.4 Qatar Recombinant Protein Therapeutics Consumption (2017-2022)
-
10.6.5 Saudi Arabia Recombinant Protein Therapeutics Consumption (2017-2022)
-
10.6.6 United Arab Emirates Recombinant Protein Therapeutics Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Recombinant Protein Therapeutics Consumption (2017-2022)
-
10.7.2 South Africa Recombinant Protein Therapeutics Consumption (2017-2022)
-
10.7.3 Egypt Recombinant Protein Therapeutics Consumption (2017-2022)
-
10.7.4 Algeria Recombinant Protein Therapeutics Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Recombinant Protein Therapeutics Consumption (2017-2022)
-
10.8.2 New Zealand Recombinant Protein Therapeutics Consumption (2017-2022)
11 Global Recombinant Protein Therapeutics Competitive Analysis
-
11.1 Roche
-
11.1.1 Roche Company Details
-
11.1.2 Roche Recombinant Protein Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Roche Recombinant Protein Therapeutics Main Business and Markets Served
-
11.1.4 Roche Recombinant Protein Therapeutics Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Biogen
-
11.2.1 Biogen Company Details
-
11.2.2 Biogen Recombinant Protein Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Biogen Recombinant Protein Therapeutics Main Business and Markets Served
-
11.2.4 Biogen Recombinant Protein Therapeutics Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Amgen
-
11.3.1 Amgen Company Details
-
11.3.2 Amgen Recombinant Protein Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Amgen Recombinant Protein Therapeutics Main Business and Markets Served
-
11.3.4 Amgen Recombinant Protein Therapeutics Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Pfizer
-
11.4.1 Pfizer Company Details
-
11.4.2 Pfizer Recombinant Protein Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Pfizer Recombinant Protein Therapeutics Main Business and Markets Served
-
11.4.4 Pfizer Recombinant Protein Therapeutics Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Merck
-
11.5.1 Merck Company Details
-
11.5.2 Merck Recombinant Protein Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Merck Recombinant Protein Therapeutics Main Business and Markets Served
-
11.5.4 Merck Recombinant Protein Therapeutics Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Sanofi
-
11.6.1 Sanofi Company Details
-
11.6.2 Sanofi Recombinant Protein Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Sanofi Recombinant Protein Therapeutics Main Business and Markets Served
-
11.6.4 Sanofi Recombinant Protein Therapeutics Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Eli Lilly
-
11.7.1 Eli Lilly Company Details
-
11.7.2 Eli Lilly Recombinant Protein Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Eli Lilly Recombinant Protein Therapeutics Main Business and Markets Served
-
11.7.4 Eli Lilly Recombinant Protein Therapeutics Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 J&J
-
11.8.1 J&J Company Details
-
11.8.2 J&J Recombinant Protein Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 J&J Recombinant Protein Therapeutics Main Business and Markets Served
-
11.8.4 J&J Recombinant Protein Therapeutics Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Ligand
-
11.9.1 Ligand Company Details
-
11.9.2 Ligand Recombinant Protein Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Ligand Recombinant Protein Therapeutics Main Business and Markets Served
-
11.9.4 Ligand Recombinant Protein Therapeutics Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Bayer
-
11.10.1 Bayer Company Details
-
11.10.2 Bayer Recombinant Protein Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Bayer Recombinant Protein Therapeutics Main Business and Markets Served
-
11.10.4 Bayer Recombinant Protein Therapeutics Product Portfolio
-
11.10.5 Recent Research and Development Strategies
12 Global Recombinant Protein Therapeutics Market Outlook by Types and Applications to 2028
-
12.1 Global Recombinant Protein Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Recombinant Hormones Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Interferons Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global Interleukins Consumption Forecast and Growth Rate (2022-2028)
-
12.1.4 Global Hematopoietic Growth Factors Consumption Forecast and Growth Rate (2022-2028)
-
12.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Recombinant Protein Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Dwarfism Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Heart Disease Consumption Forecast and Growth Rate (2022-2028)
-
12.2.4 Global Cancer Consumption Forecast and Growth Rate (2022-2028)
-
12.2.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Recombinant Protein Therapeutics Market Analysis and Outlook to 2028
-
13.1 Global Recombinant Protein Therapeutics Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Recombinant Protein Therapeutics Consumption Forecast (2022-2028)
-
13.2.2 Canada Recombinant Protein Therapeutics Consumption Forecast (2022-2028)
-
13.2.3 Mexico Recombinant Protein Therapeutics Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Recombinant Protein Therapeutics Consumption Forecast (2022-2028)
-
13.3.2 UK Recombinant Protein Therapeutics Consumption Forecast (2022-2028)
-
13.3.3 Spain Recombinant Protein Therapeutics Consumption Forecast (2022-2028)
-
13.3.4 Belgium Recombinant Protein Therapeutics Consumption Forecast (2022-2028)
-
13.3.5 France Recombinant Protein Therapeutics Consumption Forecast (2022-2028)
-
13.3.6 Italy Recombinant Protein Therapeutics Consumption Forecast (2022-2028)
-
13.3.7 Denmark Recombinant Protein Therapeutics Consumption Forecast (2022-2028)
-
13.3.8 Finland Recombinant Protein Therapeutics Consumption Forecast (2022-2028)
-
13.3.9 Norway Recombinant Protein Therapeutics Consumption Forecast (2022-2028)
-
13.3.10 Sweden Recombinant Protein Therapeutics Consumption Forecast (2022-2028)
-
13.3.11 Poland Recombinant Protein Therapeutics Consumption Forecast (2022-2028)
-
13.3.12 Russia Recombinant Protein Therapeutics Consumption Forecast (2022-2028)
-
13.3.13 Turkey Recombinant Protein Therapeutics Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Recombinant Protein Therapeutics Consumption Forecast (2022-2028)
-
13.4.2 Japan Recombinant Protein Therapeutics Consumption Forecast (2022-2028)
-
13.4.3 India Recombinant Protein Therapeutics Consumption Forecast (2022-2028)
-
13.4.4 South Korea Recombinant Protein Therapeutics Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Recombinant Protein Therapeutics Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Recombinant Protein Therapeutics Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Recombinant Protein Therapeutics Consumption Forecast (2022-2028)
-
13.4.8 Thailand Recombinant Protein Therapeutics Consumption Forecast (2022-2028)
-
13.4.9 Singapore Recombinant Protein Therapeutics Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Recombinant Protein Therapeutics Consumption Forecast (2022-2028)
-
13.4.11 Philippines Recombinant Protein Therapeutics Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Recombinant Protein Therapeutics Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Recombinant Protein Therapeutics Consumption Forecast (2022-2028)
-
13.5.2 Colombia Recombinant Protein Therapeutics Consumption Forecast (2022-2028)
-
13.5.3 Chile Recombinant Protein Therapeutics Consumption Forecast (2022-2028)
-
13.5.4 Argentina Recombinant Protein Therapeutics Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Recombinant Protein Therapeutics Consumption Forecast (2022-2028)
-
13.5.6 Peru Recombinant Protein Therapeutics Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Recombinant Protein Therapeutics Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Recombinant Protein Therapeutics Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Recombinant Protein Therapeutics Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Recombinant Protein Therapeutics Consumption Forecast (2022-2028)
-
13.6.3 Oman Recombinant Protein Therapeutics Consumption Forecast (2022-2028)
-
13.6.4 Qatar Recombinant Protein Therapeutics Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Recombinant Protein Therapeutics Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Recombinant Protein Therapeutics Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Recombinant Protein Therapeutics Consumption Forecast (2022-2028)
-
13.7.2 South Africa Recombinant Protein Therapeutics Consumption Forecast (2022-2028)
-
13.7.3 Egypt Recombinant Protein Therapeutics Consumption Forecast (2022-2028)
-
13.7.4 Algeria Recombinant Protein Therapeutics Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Recombinant Protein Therapeutics Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Recombinant Protein Therapeutics Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Recombinant Protein Therapeutics
-
Figure of Recombinant Protein Therapeutics Picture
-
Table Global Recombinant Protein Therapeutics Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Recombinant Protein Therapeutics Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Recombinant Hormones Consumption and Growth Rate (2017-2022)
-
Figure Global Interferons Consumption and Growth Rate (2017-2022)
-
Figure Global Interleukins Consumption and Growth Rate (2017-2022)
-
Figure Global Hematopoietic Growth Factors Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Diabetes Consumption and Growth Rate (2017-2022)
-
Figure Global Dwarfism Consumption and Growth Rate (2017-2022)
-
Figure Global Heart Disease Consumption and Growth Rate (2017-2022)
-
Figure Global Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Recombinant Protein Therapeutics Consumption by Country (2017-2022)
-
Table North America Recombinant Protein Therapeutics Consumption by Country (2017-2022)
-
Figure United States Recombinant Protein Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Canada Recombinant Protein Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Mexico Recombinant Protein Therapeutics Consumption and Growth Rate (2017-2022)
-
Table Europe Recombinant Protein Therapeutics Consumption by Country (2017-2022)
-
Figure Germany Recombinant Protein Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure UK Recombinant Protein Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Spain Recombinant Protein Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Belgium Recombinant Protein Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure France Recombinant Protein Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Italy Recombinant Protein Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Denmark Recombinant Protein Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Finland Recombinant Protein Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Norway Recombinant Protein Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Sweden Recombinant Protein Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Poland Recombinant Protein Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Russia Recombinant Protein Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Turkey Recombinant Protein Therapeutics Consumption and Growth Rate (2017-2022)
-
Table APAC Recombinant Protein Therapeutics Consumption by Country (2017-2022)
-
Figure China Recombinant Protein Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Japan Recombinant Protein Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure India Recombinant Protein Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure South Korea Recombinant Protein Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Recombinant Protein Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Recombinant Protein Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Recombinant Protein Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Thailand Recombinant Protein Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Singapore Recombinant Protein Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Recombinant Protein Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Philippines Recombinant Protein Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Recombinant Protein Therapeutics Consumption and Growth Rate (2017-2022)
-
Table South America Recombinant Protein Therapeutics Consumption by Country (2017-2022)
-
Figure Brazil Recombinant Protein Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Colombia Recombinant Protein Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Chile Recombinant Protein Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Argentina Recombinant Protein Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Recombinant Protein Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Peru Recombinant Protein Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Recombinant Protein Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Recombinant Protein Therapeutics Consumption and Growth Rate (2017-2022)
-
Table GCC Recombinant Protein Therapeutics Consumption by Country (2017-2022)
-
Figure Bahrain Recombinant Protein Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Recombinant Protein Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Oman Recombinant Protein Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Qatar Recombinant Protein Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Recombinant Protein Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Recombinant Protein Therapeutics Consumption and Growth Rate (2017-2022)
-
Table Africa Recombinant Protein Therapeutics Consumption by Country (2017-2022)
-
Figure Nigeria Recombinant Protein Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure South Africa Recombinant Protein Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Egypt Recombinant Protein Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Algeria Recombinant Protein Therapeutics Consumption and Growth Rate (2017-2022)
-
Table Oceania Recombinant Protein Therapeutics Consumption by Country (2017-2022)
-
Figure Australia Recombinant Protein Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Recombinant Protein Therapeutics Consumption and Growth Rate (2017-2022)
-
Table Roche Company Details
-
Table Roche Recombinant Protein Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Recombinant Protein Therapeutics Main Business and Markets Served
-
Table Roche Recombinant Protein Therapeutics Product Portfolio
-
Table Biogen Company Details
-
Table Biogen Recombinant Protein Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biogen Recombinant Protein Therapeutics Main Business and Markets Served
-
Table Biogen Recombinant Protein Therapeutics Product Portfolio
-
Table Amgen Company Details
-
Table Amgen Recombinant Protein Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Recombinant Protein Therapeutics Main Business and Markets Served
-
Table Amgen Recombinant Protein Therapeutics Product Portfolio
-
Table Pfizer Company Details
-
Table Pfizer Recombinant Protein Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Recombinant Protein Therapeutics Main Business and Markets Served
-
Table Pfizer Recombinant Protein Therapeutics Product Portfolio
-
Table Merck Company Details
-
Table Merck Recombinant Protein Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Recombinant Protein Therapeutics Main Business and Markets Served
-
Table Merck Recombinant Protein Therapeutics Product Portfolio
-
Table Sanofi Company Details
-
Table Sanofi Recombinant Protein Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Recombinant Protein Therapeutics Main Business and Markets Served
-
Table Sanofi Recombinant Protein Therapeutics Product Portfolio
-
Table Eli Lilly Company Details
-
Table Eli Lilly Recombinant Protein Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly Recombinant Protein Therapeutics Main Business and Markets Served
-
Table Eli Lilly Recombinant Protein Therapeutics Product Portfolio
-
Table J&J Company Details
-
Table J&J Recombinant Protein Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table J&J Recombinant Protein Therapeutics Main Business and Markets Served
-
Table J&J Recombinant Protein Therapeutics Product Portfolio
-
Table Ligand Company Details
-
Table Ligand Recombinant Protein Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ligand Recombinant Protein Therapeutics Main Business and Markets Served
-
Table Ligand Recombinant Protein Therapeutics Product Portfolio
-
Table Bayer Company Details
-
Table Bayer Recombinant Protein Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Recombinant Protein Therapeutics Main Business and Markets Served
-
Table Bayer Recombinant Protein Therapeutics Product Portfolio
-
Figure Global Recombinant Hormones Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Interferons Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Interleukins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hematopoietic Growth Factors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Dwarfism Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Heart Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Recombinant Protein Therapeutics Consumption Forecast by Country (2022-2028)
-
Table North America Recombinant Protein Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure United States Recombinant Protein Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Recombinant Protein Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Recombinant Protein Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Recombinant Protein Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure Germany Recombinant Protein Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Recombinant Protein Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Recombinant Protein Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Recombinant Protein Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Recombinant Protein Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Recombinant Protein Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Recombinant Protein Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Recombinant Protein Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Recombinant Protein Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Recombinant Protein Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Recombinant Protein Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Recombinant Protein Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Recombinant Protein Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Recombinant Protein Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure China Recombinant Protein Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Recombinant Protein Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Recombinant Protein Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Recombinant Protein Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Recombinant Protein Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Recombinant Protein Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Recombinant Protein Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Recombinant Protein Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Recombinant Protein Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Recombinant Protein Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Recombinant Protein Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Recombinant Protein Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Recombinant Protein Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure Brazil Recombinant Protein Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Recombinant Protein Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Recombinant Protein Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Recombinant Protein Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Recombinant Protein Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Recombinant Protein Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Recombinant Protein Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Recombinant Protein Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Recombinant Protein Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Recombinant Protein Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Recombinant Protein Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Recombinant Protein Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Recombinant Protein Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Recombinant Protein Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Recombinant Protein Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Recombinant Protein Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Recombinant Protein Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Recombinant Protein Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Recombinant Protein Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Recombinant Protein Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Recombinant Protein Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure Australia Recombinant Protein Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Recombinant Protein Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
